Skip to main content
. 2012 Jun 23;379(9834):2364–2372. doi: 10.1016/S0140-6736(12)60738-7

Figure 2.

Figure 2

Effects of rt-PA on outcomes at final follow-up

Data are numbers, unless otherwise indicated. Treatment was administered up to 6 h after the stroke. rt-PA=recombinant tissue plasminogen activator. IST-3=Third International Stroke Trial. mRS=modified Rankin Scale.